Frontier Biotechnologies Inc.
Frontier Biotechnologies Inc. has 1 licensing announcement in this dataset, dated 2026-02-23.
- Country / operating region
- China
- Ticker
- 688221.SH
- Headquarters
- 查無
- Founded
- 2013
- Business
- Biopharmaceutical research and development
- Website
- www.frontierbiotech.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| Two siRNA candidates | 查無 | other | preclinical | 2026-02-23 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 3) LIMITED | Two siRNA candidates | USD 40m | USD 13m | ≤ USD 950m | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 3) LIMITED | Worldwide | Tiered royalties on worldwide net sales. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無